LEGN Legend Biotech Corporation

track record → $23.56 -0.09 (-0.4%)
Get emailed when LEGN changes direction
Mkt Cap $5B 52wk $16.24 - $45.30 Earnings 2026-05-13
Factor Model (net -3.1)

Factor Model

net -3.1
Est. Revisions
-1.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

6d ago HC Wainwright & Co. reit LEGN: Buy → Buy
Fundamentals & Data ▾
Legend Biotech Corporation Healthcare · Biotechnology
Mkt Cap
$5B
Beta
0.08
52w Range
$16.24 - $45.30
Short Interest
18.7M 25.72%
Days to Cover
13.6 -7%
Technicals downtrend
from 52w Hi
-8.8%
1w return
-5.7%
Analysts
mixed
EPS Estimate
$-0.17 -88.9% 30d 0up / 1dn
Est. Dispersion
0% 1 analysts
Analyst Target
$57 $21 - $86
Options P/C
1.11
Fund Convergence
strong Two Sigma, Renaissance, Citadel
Financials
Revenue
$306M +64% YoY
FCF
$-25M
Gross Margin
60%
Op Margin
-7%
Momentum: accelerating
Top Holders
Two Sigma $15M
Renaissance $9M
Citadel $7M
2 signals · latest 6d ago

Get alerted when LEGN changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.